Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004057
Status:
COMPLETED
Last Update Posted:
2013-06-21
First Post:
1999-12-10
Brief Title:
Paclitaxel Plus L-778123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
| Unspecified Adult Solid Tumor Protocol Specific |
Keywords:
| Name | View |
|---|---|
| splenic marginal zone lymphoma | View |
| recurrent adult Hodgkin lymphoma | View |
| unspecified adult solid tumor protocol specific | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent adult diffuse small cleaved cell lymphoma | View |
| recurrent adult diffuse mixed cell lymphoma | View |
| recurrent adult diffuse large cell lymphoma | View |
| recurrent adult immunoblastic large cell lymphoma | View |
| recurrent adult lymphoblastic lymphoma | View |
| recurrent adult Burkitt lymphoma | View |
| recurrent adult T-cell leukemialymphoma | View |
| recurrent mantle cell lymphoma | View |
| angioimmunoblastic T-cell lymphoma | View |
| anaplastic large cell lymphoma | View |
| recurrent marginal zone lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |